Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 May-Jun;34(3):1283-1288.
doi: 10.21873/invivo.11903.

Salvage Re-irradiation Options in Adult Medulloblastoma: A Case Report and Review of the Literature

Francesco Cuccia  1   2 , Gianluca Mortellaro  3 , Lucia Ognibene  4 , Giuseppe Craparo  5 , Antonio Lo Casto  6 , Giuseppe Ferrera  3
Affiliations
Review

Salvage Re-irradiation Options in Adult Medulloblastoma: A Case Report and Review of the Literature

Francesco Cuccia et al. In Vivo. 2020 May-Jun.

Abstract

Background/aim: Medulloblastoma is a rare tumor of adult age, while it occurs more frequently in children. Given the rarity, there is a lack of evidence for the treatment of recurrent disease. Few data are available about salvage re-irradiation collecting very heterogeneous series.

Case report: A 51-year-old male presented with headache, nausea, double vision, and gait disorders. A contrast-enhanced brain-MRI showed the presence of multifocal medulloblastoma. After surgery, adjuvant craniospinal radiotherapy was performed, chemotherapy was stopped due to toxicity. After 27 months, a new MRI and a Methionine-PET revealed a late pontocerebellar relapse; multidisciplinary board decided for a SBRT treatment. The second course of RT was well tolerated and 14 months later, the patient is alive in good general conditions, with no evidence of disease.

Conclusion: Our experience supports the use of salvage stereotactic radiotherapy as a safe and effective treatment option.

Keywords: Medulloblastoma; adult patients; re-irradiation.

PubMed Disclaimer

Conflict of interest statement

The Authors declare no conflicts of interest.

Figures

Figure 1
Figure 1. Preoperative brain MRI in T1-weighted contrast enhanced (right) and T2-weighted (left) sequence
Figure 2
Figure 2. Brain MRI in T1-weighted contrast enhanced before stereotactic radiotherapy (left) and after 14 months (right)
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Farwell JR, Dohrmann GJ, Flannery JT. Medulloblastoma in childhood: an epidemiological study. J Neurosurg. 1984;61(4):657–664. doi: 10.3171/jns.1984.61.4.0657. - DOI - PubMed
    1. Balducci M, Chiesa S, Chieffo D, Manfrida S, Dinapoli N, Fiorentino A, Miccichè F, Frascino V, Anile C, Valentini V, De Bari B. The role of radiotherapy in adult medulloblastoma: long-term single-institution experience and a review of the literature. J Neurooncol. 2012;106(2):315–323. doi: 10.1007/s11060-011-0665-7. - DOI - PubMed
    1. Gliemroth J, Kehler U, Knopp U, Reusche E, Nowak G. A multifocal cerebellar and supratentorial medulloblastoma in an adult. Acta Neurochir (Wien) 1998;140(7):723–724. doi: 10.1007/s007010050169. - DOI - PubMed
    1. Spagnoli D, Tomei G, Masini B, De Santis A, Grimoldi N, Lucarini C, Gaini SM. A case of multifocal cerebellar medulloblastoma in an adult patient. J Neurosurg Sci. 1990;34(3-4):323–325. - PubMed
    1. Shen WC, Yang CF. Multifocal cerebellar medulloblastoma: CT findings. J Comput Assist Tomogr. 1988;12(5):894. doi: 10.1097/00004728-198809010-00037. - DOI - PubMed

LinkOut - more resources